Form 4 for LEXX Lexaria Bioscience Corp.
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-29 · accession 0001348362-25-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-30 | 2025-07-29 | LEXX | CHRISTOPHER RICHARD | CEO, Dir | P - Purchase | $0.91 | +15.0K | 65.0K | +30% | +$13.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2025-07-29 | P | A | 15,000 | $0.91 | 65,000 | D | — | — |